← Back to Search

Luci Coach Assisted Intervention for Cognitive Decline

N/A
Waitlist Available
Led By Sylvie Belleville, PhD
Research Sponsored by LuciLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Committed not to participate in another program related to any of the three intervention domains for the duration of the trial;
Low adherence to the Mediterranean-type diet defined as a score of ≤ 8 on the adapted Canadian Mediterranean Diet Scale, and no severe food allergy or intolerance or history of eating disorder.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, week 12, week 24
Awards & highlights

Study Summary

The overarching aim is to develop and deploy a multidomain intervention delivered on a mobile application to help middle-aged to older adults reduce their risk for dementia by improving a set of modifiable lifestyle risk factors associated with cognitive decline/dementia. This registration concerns the Pilot Feasibility study which examines different aspects of feasibility in a small-scale randomized pilot study, before implementing an efficacy study on a larger sample. A secondary objective is to determine whether the program can result in a larger improvement on risk factors (measured with Behavioural Risk outcomes) compared to a control intervention. It is expected that persons enrolled in the Luci program show larger change in Behavioural Risk outcomes than those enrolled in the comparator condition.

Eligible Conditions
  • Risky Behaviors
  • Cognitive Decline

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on a weekly basis from week 1 to 12, and every 2 weeks from week 13 to 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and on a weekly basis from week 1 to 12, and every 2 weeks from week 13 to 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of randomization
Enrollment Ratio
Program adherence
+2 more
Secondary outcome measures
Action Taken
Change from baseline in Cognitive Engagement
Change from baseline in Cognitive Performance
+18 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Luci InterventionExperimental Treatment1 Intervention
Participants enrolled in this group will receive the Luci intervention for a 24-week period.
Group II: Wait-list ControlActive Control1 Intervention
Participants in the waiting-list control group will not receive any intervention during the study. They will be invited to participate to the program at the end of the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Luci Coach Assisted Intervention
2021
N/A
~120

Find a Location

Who is running the clinical trial?

Centre de Recherche de l'Institut Universitaire de Geriatrie de MontrealOTHER
22 Previous Clinical Trials
8,769 Total Patients Enrolled
1 Trials studying Cognitive Decline
41 Patients Enrolled for Cognitive Decline
Sojecci II LtdUNKNOWN
1 Previous Clinical Trials
41 Total Patients Enrolled
1 Trials studying Cognitive Decline
41 Patients Enrolled for Cognitive Decline
LuciLabLead Sponsor
1 Previous Clinical Trials
41 Total Patients Enrolled
1 Trials studying Cognitive Decline
41 Patients Enrolled for Cognitive Decline

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~36 spots leftby Mar 2025